GO:1904791 negative regulation of shelterin complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904791 describes any process that stops, prevents, or reduces the frequency, rate, or extent of shelterin complex assembly.
• The shelterin complex is composed of TRF1, TRF2, POT1, TPP1, TERF1, and TERF2IP, and its assembly is essential for telomere protection.
• Negative regulation of shelterin assembly can occur through downregulation or inhibition of shelterin components such as TRF1, TRF2, and TPP1.
• Disruption of shelterin assembly leads to telomere dysfunction, genomic instability, and increased sensitivity to DNA-damaging agents.
• Studying GO:1904791 is critical for understanding cancer, aging, and telomere-related diseases.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of negative regulators of shelterin assembly.
Description
The shelterin complex is a six-protein assembly that binds telomeric DNA and protects chromosome ends from being recognized as DNA damage. Its assembly is tightly regulated to ensure proper telomere function and genome stability. The Gene Ontology term GO:1904791, negative regulation of shelterin complex assembly, encompasses any process that stops, prevents, or reduces the assembly of this complex. Understanding this regulatory process is essential because aberrant shelterin assembly is linked to cancer, premature aging, and radiation sensitivity. Researchers study GO:1904791 to identify molecular brakes that control telomere protection and to develop therapeutic strategies targeting telomere maintenance.
negative regulation of shelterin complex assembly At A Glance
| GO ID | GO:1904791 |
|---|---|
| GO term | negative regulation of shelterin complex assembly |
| Ontology | biological_process |
| Synonym | down regulation of Pot1 complex assembly; inhibition of telosome assembly; negative regulation of shelterin complex formation |
| Major function | Stops, prevents, or reduces the assembly of the shelterin complex at telomeres |
| Related complex | Shelterin (telosome) composed of TRF1, TRF2, POT1, TPP1, TERF1, TERF2IP |
| Key regulators | TRF1, TRF2, TPP1 |
| Disease relevance | Cancer, telomere dysfunction, radiation sensitivity |
What Is GO:1904791?
GO:1904791 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of shelterin complex assembly. In other words, it covers molecular events that inhibit the formation of the shelterin complex, also known as the telosome or Pot1 complex. This negative regulation can occur through downregulation or inhibition of shelterin components such as TRF1, TRF2, or TPP1.
Why Is negative regulation of shelterin complex assembly Important in Cell Biology?
Negative regulation of shelterin complex assembly is crucial because the shelterin complex safeguards chromosome ends; its dysregulation leads to telomere uncapping, DNA damage response activation, and genomic instability. This process is implicated in cancer, where altered shelterin assembly can promote immortalization, and in premature aging syndromes. Understanding GO:1904791 provides insights into telomere biology and identifies targets for cancer therapy and radiation sensitization.
• Maintains telomere integrity by preventing inappropriate shelterin assembly.
• Dysregulation causes telomere dysfunction and chromosomal instability.
• Linked to cancer development through telomere maintenance mechanisms.
• Modulates sensitivity to radiation and DNA-damaging agents.
• Involved in cellular aging and senescence pathways.
• Provides targets for therapeutic intervention in telomere-related diseases.
• Essential for understanding cell cycle-dependent telomere regulation.
• Impacts stem cell function and tissue homeostasis.
What Happens During negative regulation of shelterin complex assembly?
Downregulation of shelterin components
In simple terms: When cells need to reduce shelterin assembly, they can simply make less of its protein parts.
Negative regulation of shelterin complex assembly can be achieved by reducing the expression or stability of shelterin components such as TRF1, TRF2, or TPP1. For example, suppression of TPP1 results in telomere dysfunction and impaired shelterin assembly. Similarly, TRF1 controls telomere length and mitotic fidelity, and its downregulation negatively impacts shelterin function.
Inhibition of protein-protein interactions
In simple terms: Blocking the physical interactions between shelterin proteins prevents the complex from forming.
Shelterin assembly relies on specific protein-protein interactions, including TRF1-TRF2 and TPP1-POT1 associations. Negative regulation can occur by disrupting these interactions, thereby preventing complex formation. Molecular recognition studies of TRF proteins with telomeric DNA highlight the importance of these interactions for assembly.
Cell cycle-dependent regulation
In simple terms: The assembly of shelterin can be turned down at specific phases of the cell cycle.
TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner, indicating that negative regulation of shelterin assembly may be coordinated with the cell cycle. This ensures proper telomere protection during DNA replication and mitosis.
Post-translational modifications
In simple terms: Chemical tags added to shelterin proteins can act as switches to reduce assembly.
Although specific post-translational modifications that negatively regulate shelterin assembly are not fully detailed in the provided literature, general mechanisms such as phosphorylation or ubiquitination could modulate protein stability and interactions. Further research is needed to pinpoint exact modifications.
Key Genes Involved in GO:1904791 negative regulation of shelterin complex assembly
The following genes and proteins are central to the regulation of shelterin complex assembly and its negative control.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRF1 (TERF1) | Binds telomeric DNA and regulates telomere length | Knockout leads to telomere elongation and mitotic defects |
| TRF2 (TERF2) | Protects telomeres and controls nucleosome organization | Dominant-negative mutants cause telomere deprotection |
| TPP1 (ACD) | Interacts with POT1 and regulates telomerase | Suppression causes telomere dysfunction and radiation sensitivity |
| POT1 | Binds single-stranded telomeric DNA | Mutations linked to cancer predisposition |
| TERF2IP (RAP1) | Part of shelterin complex, regulates telomere length | Knockout affects telomere protection |
| TERF1 | Alternative name for TRF1 | Same as TRF1 |
| TERF2 | Alternative name for TRF2 | Same as TRF2 |
| ACD | Alternative name for TPP1 | Same as TPP1 |
| TRF1-interacting protein | Modulates TRF1 function | Potential target for telomere regulation |
| Telomerase | Elongates telomeres, counteracted by shelterin | Inhibited by TPP1 suppression |
| DNA damage response proteins | Activated upon shelterin disruption | Markers of telomere dysfunction |
| Histones | Organize telomeric chromatin | TRF2 controls their cell cycle-dependent organization |
| Shelterin complex | Six-protein complex protecting telomeres | Target for negative regulation |
| POT1-TPP1 heterodimer | Key subcomplex for telomere protection | Disruption leads to telomere uncapping |
| TRF1-TRF2 heterodimer | Bridges double-stranded telomeric DNA | Essential for assembly |
How Is negative regulation of shelterin complex assembly Regulated?
Negative regulation of shelterin complex assembly is itself regulated at multiple levels. Cell cycle-dependent mechanisms control TRF2-mediated nucleosome organization. Additionally, the abundance of shelterin components like TPP1 and TRF1 is regulated by transcriptional and post-transcriptional pathways, as their suppression leads to reduced assembly. However, specific upstream regulators such as mTOR or ISR are not documented in the provided literature for this term.
negative regulation of shelterin complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TPP1 | Osteosarcoma, radiation sensitivity | TPP1 knockout in osteosarcoma cell lines |
| TRF1 | Epithelial cancer, mitotic defects | Conditional TRF1 knockout in epithelial cells |
| TRF2 | Telomere deprotection, cancer | TRF2 dominant-negative overexpression |
| POT1 | Cancer predisposition | POT1 point mutations in cancer cell lines |
| TERF2IP | Telomere length regulation | TERF2IP knockout models |
Cancer and Telomere Maintenance
Dysregulation of shelterin assembly is a hallmark of cancer, where telomere protection is altered to support unlimited proliferation. TRF1 controls telomere length and mitotic fidelity in epithelial homeostasis, and its loss can promote genomic instability. Suppression of TPP1 enhances radiation sensitivity in telomerase-negative osteosarcoma cells, suggesting that negative regulation of shelterin assembly can be exploited in cancer therapy.
Telomere Dysfunction and Radiation Sensitivity
Inhibition of shelterin components such as TPP1 results in telomere dysfunction and increased sensitivity to radiation. This links GO:1904791 to cellular responses to DNA damage and potential radiosensitization strategies.
Aging and Degenerative Diseases
Proper shelterin assembly is critical for telomere maintenance, and its negative regulation may contribute to premature aging. Cell cycle-dependent control of telomeric chromatin by TRF2 suggests that disrupting this regulation could accelerate telomere shortening and aging phenotypes.
From negative regulation of shelterin complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TPP1 reduce shelterin assembly? | TPP1 knockout cell line |
| How does TRF1 downregulation affect telomere length? | TRF1 knockout or knockdown |
| What is the effect of TRF2 inhibition on nucleosome organization? | TRF2 dominant-negative mutant |
| Can point mutations in POT1 disrupt shelterin assembly? | POT1 point mutation knock-in |
| Does overexpression of a negative regulator block shelterin assembly? | Overexpression of candidate inhibitor |
| How does cell cycle phase affect shelterin assembly? | Synchronized cell populations with tagged shelterin components |
How to Study the negative regulation of shelterin complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Telomere restriction fragment (TRF) assay | Telomere length | Assessing impact of shelterin disruption |
| Chromosome orientation FISH (CO-FISH) | Telomere sister chromatid exchange | Detecting telomere dysfunction |
| Telomere-induced foci (TIF) assay | DNA damage at telomeres | Quantifying shelterin loss |
| Co-immunoprecipitation | Protein-protein interactions | Detecting shelterin assembly |
| RNA-seq | Gene expression | Measuring shelterin component levels |
| Western blot | Protein abundance | Validating knockdown/knockout |
| Immunofluorescence | Protein localization | Visualizing shelterin at telomeres |
| Cell cycle synchronization | Cell cycle phase | Studying phase-dependent regulation |
Telomere Function Assays
Telomere dysfunction can be assessed using telomere length measurements (e.g., TRF assay), chromosome orientation FISH (CO-FISH), and telomere-induced foci (TIF) analysis. These methods quantify the consequences of negative regulation of shelterin assembly.
Protein Interaction Studies
Co-immunoprecipitation, pull-down assays, and proximity ligation assays can detect shelterin complex assembly and its disruption. Molecular recognition studies of TRF proteins with telomeric DNA provide structural insights.
Gene Expression Analysis
RNA-seq and qPCR can measure the expression levels of shelterin components such as TRF1, TRF2, and TPP1 to infer negative regulation.
Imaging and Cell Cycle Analysis
Fluorescence microscopy with tagged shelterin proteins and cell cycle synchronization can reveal cell cycle-dependent assembly and its negative regulation.
How CRISPR Can Be Used to Study GO:1904791 negative regulation of shelterin complex assembly
Knockout
CRISPR knockout of shelterin genes such as TPP1 or TRF1 can model negative regulation by eliminating the component, leading to reduced shelterin assembly and telomere dysfunction. These models are valuable for studying the consequences of loss of function.
Point Mutation
Introducing point mutations in shelterin genes (e.g., POT1) can disrupt specific protein-protein or protein-DNA interactions, mimicking negative regulation of assembly. Such models help dissect domain-specific functions.
Knock-in
Knock-in of tagged shelterin components (e.g., GFP-TRF2) allows real-time visualization of assembly and its negative regulation in live cells. This approach is useful for cell cycle studies.
Overexpression
Overexpression of a negative regulator or a dominant-negative shelterin mutant (e.g., TRF2 dominant-negative) can actively block shelterin assembly. This models the inhibition of complex formation.
How EDITGENE Supports negative regulation of shelterin complex assembly Research
Researchers studying negative regulation of shelterin complex assembly-related genes often need to determine whether a candidate gene is causally involved in telomere protection or whether its manipulation alters shelterin assembly. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of shelterin complex assembly research.
Frequently Asked Questions About negative regulation of shelterin complex assembly
What is GO:1904791?
GO:1904791 is the Gene Ontology term for negative regulation of shelterin complex assembly, describing any process that stops, prevents, or reduces the assembly of the shelterin complex.
What genes are involved in negative regulation of shelterin complex assembly?
Key genes include TRF1, TRF2, TPP1, POT1, and TERF2IP, which are components of the shelterin complex and can be downregulated or inhibited.
How is shelterin complex assembly negatively regulated?
It can be negatively regulated by reducing the expression of shelterin components, disrupting protein-protein interactions, or cell cycle-dependent mechanisms.
Why is negative regulation of shelterin assembly important in cancer?
Dysregulation of shelterin assembly contributes to telomere maintenance and genomic instability in cancer, making it a potential therapeutic target.
What diseases are associated with shelterin complex assembly?
Cancer, radiation sensitivity, and premature aging are linked to altered shelterin assembly.
What experimental models are used to study GO:1904791?
CRISPR knockout, point mutation, knock-in, and overexpression models in cell lines are commonly used.
How can I measure shelterin complex assembly?
Techniques include co-immunoprecipitation, immunofluorescence, and telomere function assays such as TIF and CO-FISH.
What is the role of TPP1 in shelterin assembly?
TPP1 interacts with POT1 and is essential for shelterin function; its suppression leads to telomere dysfunction.
Does TRF2 regulate shelterin assembly in a cell cycle-dependent manner?
Yes, TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner, influencing shelterin assembly.
Can CRISPR be used to study negative regulation of shelterin assembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful tools to dissect this process.
Conclusion
GO:1904791, negative regulation of shelterin complex assembly, is a critical biological process that controls telomere protection and genome stability. Its dysregulation is implicated in cancer, aging, and radiation sensitivity. By leveraging CRISPR-based models and advanced bioinformatics, researchers can uncover the molecular mechanisms governing this process and identify new therapeutic targets.
References
- 1. Wieczór M et al.. 2014. Molecular recognition in complexes of TRF proteins with telomeric DNA.. PLoS One 9(2):e89460 PMID: 24586793
- 2. Galati A et al.. 2012. TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner.. PLoS One 7(4):e34386 PMID: 22536324
- 3. Muñoz P et al.. 2009. TRF1 controls telomere length and mitotic fidelity in epithelial homeostasis.. Mol Cell Biol 29(6):1608-25 PMID: 19124610
- 4. Qiang W et al.. 2014. Suppression of telomere-binding protein TPP1 resulted in telomere dysfunction and enhanced radiation sensitivity in telomerase-negative osteosarcoma cell line.. Biochem Biophys Res Commun 445(2):363-8 PMID: 24513288
